IBO - IMPACT BIOMEDICAL INC.

0.5495
0.052   9.463%

Share volume: 1,354,232
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.09%

PREVIOUS CLOSE
CHG
CHG%
$0.50
0.05
0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 35%
Dept financing 49%
Liquidity 15%
Performance 60%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
7.70%
1 Month
14.41%
3 Months
-71.08%
6 Months
-71.08%
1 Year
-71.08%
2 Year
-71.08%
Key data
Stock price
$0.55
P/E Ratio 
0.00
DAY RANGE
$0.49 - $0.59
EPS 
-$2.48
52 WEEK RANGE
$0.37 - $6.17
52 WEEK CHANGE
-$71.08
MARKET CAP 
15.598 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$33,836,468
AVERAGE 30 VOLUME 
$11,184,062
Company detail
CEO: Frank D. Heuszel
Region: US
Website: www.impactbiomedinc.com
Employees: 0
IPO year: 2024
Issue type:
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Impact Biomedical, Inc. (“IBIO”) currently is a holding company operating mainly through our majority owned subsidiary, Global BioLife, Inc., which was incorporated on April 14, 2017. Impact BioMedical Inc. is a Nevada corporation and was incorporated in October 2018. Our principal executive offices are located at 1400 Broadfield Blvd., Suite 130, Houston, Texas.

Recent news
loading